We, therefore, investigated the involvement of ET-1-driven CAFs in mediating early transcoelomic metastasis and tested the possibility that therapeutic interventions targeting ET-1 receptors could disrupt the interplay between cancer cells and CAFs, preventing metastatic implantation in the peritoneum and beyond. This evidence concerns the gene EDN1 and cancer.